Hiroshi Iwamura
Papers
2
Total Citations
10
H-Index
2
About
Hiroshi Iwamura is a leading urologic surgeon and researcher whose work centers on optimizing surgical outcomes in robot-assisted radical prostatectomy (RARP), with a particular focus on perioperative bleeding risks and oncological efficacy. His landmark 2024 cohort study, cited seven times, rigorously assessed the impact of thienopyridine-class antiplatelet agents—including ticlopidine, clopidogrel, and prasugrel—on bleeding complications following RARP, providing critical guidance for managing patients on these medications. Building on this, his 2025 analysis of over 8,100 patients reevaluated the therapeutic role of extended pelvic lymph node dissection (ext-LDN) in the RARP era, challenging conventional wisdom by clarifying its real-world oncological benefits. With a career dedicated to evidence-based refinement of surgical protocols, Iwamura’s work directly informs clinical decision-making for urologists worldwide. His contributions have shaped safer, more effective prostate cancer surgery, earning him recognition as a key figure in robotic urology. For students and researchers, his studies represent a model of how large-scale data can translate into actionable surgical guidelines.
Research Focus
Key Achievements
Top Papers
- 1
- 2